-
Surfshark Adds Real-Time Call Protection to iOS App in Version 5.3.0
-
Samsung Galaxy Buds Active Leak Reveals ANC, Ear-Hook Design and One UI 9.5 Integration
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
-
Egypt and Syria Sign Agreement to Restore Direct Flights After 14-Year Hiatus
-
Professor Shahida Moosa Pioneers Medical Genomics in South Africa Amid Testing Shortages
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Texas Marijuana Decriminalization Faces Uncertain Future Under New Attorney General
-
Anthropic Sets Record $81.3 Billion IPO Valuing AI Firm at $1.5 Trillion
-
Early Black Friday Laptop Deals: MacBook Neo, IdeaPad Slim 5x, and Surface Laptop Prices Drop
-
eThekwini Faces R6.5bn Flood Claim from Toyota’s Insurer
-
2026 East Bay Nosh Awards Voting Opens for Food and Drink Favorites
-
Jerash Holdings Partners with International Finance Corporation (IFC) to Pursue EDGE Gender Certification
-
Arrive AI Eliminates All Debt Through Preferred Equity Exchange
-
QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
-
More Than Half of Teen AI Chatbot Users Use Them Daily, and 46% Say It Feels Like Talking to a Human, New Family Online Safety Institute Research Finds
-
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington's Disease Patients - U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
-
MicroVision and Blue-Band to Support $3 Million Federally Funded Intelligent Transportation Initiative in Louisville, Kentucky
-
The 2026 MDaudit Annual Benchmark Report Spotlights AI's Impact on Financial Risk as Payer Denials and Audits Continue an Upward Trajectory
-
Metano Emerges From Stealth to Unify AI Agent Security Across the Enterprise
-
Lumber's Union CBA Agent Launches in Sage Agent Marketplace to Help Simplify Union Payroll Compliance
-
ATWEC Technologies, Inc. (OTCID: ATWT) Engages Michael Gillespie & Associates, PLLC to Audit Fiscal 2026 and 2025 Consolidated Financial Statements and Changes Fiscal Year End to October 31
-
Vogenx Set to Join the Russell 2000(R), Russell 3000(R), and Russell Microcap(R) Indexes
-
Stemtech Corporation Partners with Fitness Icon Tony Little to Launch Stemtech Biosciences Digital Campaign
-
Go Green Global Technologies Corp. Appoints Dennis Beckert as Interim Chief Executive Officer
-
InstaLILY Launches Lily for Sales on Microsoft Dynamics 365, Where Sellers and AI Agents Work Together in Shared Rooms
-
Wave AI, the AI Note Taker for In-Person Meetings, Passes 5 Million Recorded Hours
-
Increasing Electrification Raises Grid Risk and Cost Pressure for Industrial Sites, ABI Research Finds
-
After 20 Years of Modernizing Other Companies' Software, Polcode Turns the Lens on Itself
-
NoHo, Inc. Acquires Four Placer Gold Claims in Clark County, Nevada from Gold Stake Mining Inc.
-
Making the Most of a Long Weekend Without Leaving Town
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
IRS Shuts Down FIRE Today: What Information Return Filers Need to Know Before the 2027 Filing Season
-
Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
-
Trustpoint Xposure Completes More Than 200 AI Visibility Audits Across Professional Services
-
Gamma Resources Announces Expansion of Mesa Arc Uranium Project in New Mexico to 4,760 Acres, Completes Radon Flux Baseline Survey
-
Golden Minerals Completes Drilling Desierto, Argentina
-
Guanajuato Silver Reports Q3 Operating and Financial Results
-
Helio Corporation Engages CORE IR to Provide Investor Relations, Capital Markets Advisory and Media Relations Services
-
Greene Concepts Connects Consumer Needs with Manufacturing Strategy
-
Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
-
Skilled Nursing Facilities Face 2027 Revenue Cycle Reckoning as Payer Burdens Reshape Admissions and Outsourcing
-
Who Is the Best MTF Top Surgeon?
-
APPA Launches 2026 Pet Industry Holiday Gift Guide, Backed by New Pet Gifting Data
-
United Bancorp, Inc. Increases its Fourth Quarter Cash Dividend Payment to $0.20 per Share, which Produces a Forward Yield of 5.4%
-
moveBuddha Doubles Moving Company Database to More Than 9,000 U.S. Movers
Trump tariffs unnerve locals in Irish 'pharma' hub
Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.
The area around the village of Ringaskiddy and its port in Cork harbour has emerged in recent decades as a base for US pharma giants where products such as Pfizer's Viagra pills are made and shipped off to the United States and worldwide.
Pharmaceuticals are now the motor of Ireland's economy, accounting for around 100 billion euros ($114 billion) in 2024, almost half of all Irish exports, and up around 30 percent from the previous year.
The sector also provides an estimated 20,000 well-paid jobs in County Cork, most of them around Ringaskiddy and the neighbouring commuter town of Carrigaline, and flushes a corporate tax bounty into the Irish exchequer.
But local people are sweating that the good times could end as Ireland has found itself in the crosshairs of the US president's tariff war.
Trump has warned repeatedly that pharmaceuticals are in his sights and that special tariffs for the sector are imminent.
Drug manufacturing "is in other countries, largely made in China, a lot of it made in Ireland... Ireland was very smart. We love Ireland. but we're going to have that," he said last month.
This week, Trump trained his eye on China and announced a 90-day tariff pause for the rest of the world, just hours after he said the pharma companies are "going to come back" to the United States due to tariffs, fuelling panicked uncertainty about the future in Cork.
"There's a lot of stress out there," Audrey Buckley, a councillor in Ringaskiddy, told AFP overlooking a construction site where a new motorway will connect the factories to the port.
"Parents are saying to me, 'Oh my God, should my daughter buy her first home, she's in the process of going through a mortgage. Will she have a job in a year's time?'"
Buckley remembers "the excitement" when Pfizer first appeared in the 1970s, kickstarting the area's development.
She finished school in the 1980s, a decade marked by economic depression and high unemployment in Ireland, when many young people were forced to emigrate to find work.
"Now many of us are thinking like, will our own children have to emigrate again?" she said.
- 'Doom and gloom' -
At Ringaskiddy's village bar "The Ferry Boat Inn" -- dubbed by locals "the FBI" -- daily chatter among customers gravitates toward Trump's latest manoeuvres, according to bartender Kelly Davis.
"If everything was to be uprooted and brought back to America it would send shockwaves through the village," the 39-year-old told AFP between pulling pints of Cork's locally made Murphy's stout.
On her way home after work, Shirin Banjwani, an analytics developer at one of the US-owned plants, admitted to AFP near Ringaskiddy port that she was "worried" about losing her job.
But the 29-year-old, originally from India, who works for Thermo Fisher Scientific, said the size of the plants means it would "take like five to six years" for them to shift to the United States if it happens.
"If Trump is planning to do that, it will take a lot of time," she said.
Six kilometres (3.7 miles) up the road, the population of Carrigaline has soared in line with employment growth at the factories over the decades.
New residential developments have mushroomed around the town, its population doubling to 20,000 in two decades, up from 1,000 in the early 1970s.
"This town used to be a village. Once the pharmaceuticals came, it changed everything. It has boomed," said Betty O'Riordan, a "Tidy Towns" group volunteer painting a park bench.
"A trade war will affect everybody, all those people with mortgages and high-purchase cars, where are they going to go?" the 70-year-old retired civil servant told AFP.
The owner of a swanky restaurant on Carrigaline's main street declined to comment, saying only that "there's too much doom and gloom already, no need for me to add more".
In Cork city's UCC university, Seamus Coffey, an economics lecturer, cautioned against doom-mongering.
"I think those factories are here for the time being. They'll see out their life cycle in Ireland," Coffey told AFP in the university's quadrangle.
"If tariffs were to become a permanent feature of global trade, and if there are changes, we'll see it further down the line with pipeline decisions about next investments," he said.
D.Kaufman--AMWN